Venture Research Institute Announces Plans for FDA Anti-cancer Vaccine Trials

Published: Apr 11, 2007

LAKE FORREST, Calif.--(BUSINESS WIRE)--VRI has recently acquired exclusive licensing rights of patented technologies developed by the South Alabama Medical Science Foundation (SAMSF). The exclusive rights granted to VRI allow it to seek approval, development, joint venturing and marketing of any possible applications in the diagnosis and treatment of cancer.

Back to news